Navigation Links
Urgent Care Provider NextCare Announces new Board of Directors
Date:7/18/2008

Prestigious Healthcare Leaders to Offer Counsel for Growing Immediate Care Clinic Provider NextCare

Mesa, AZ (PRWEB) July 18, 2008 -- Immediate care clinic NextCare (www.nextcare.com), the world's largest privately owned urgent care provider, announced the addition of a prestigious group of leaders who will serve as the company's new Board of Directors. Those joining the counsel include Fred L. Brown, MBA, FACHE, Breaux B. Castleman, and David Lowenberg.

NextCare has undergone significant growth since 2005 and is now the largest privately held, multi-state urgent care provider in the country. The healthcare organization is prepared to launch a strategic growth plan beginning in 2008.

"Our Board Members' expertise will guide our decision-making and assist us in growing the business without ever losing sight of clinical quality and extraordinary service," stated Laurel Stoimenoff, President of NextCare.

Brown has served in many prominent leadership roles; he is currently Immediate Past Chairman of the Joint Commission and Immediate Past Chairman of The National Kidney Foundation. Brown is known for his expertise in healthcare integration, governance, operations, public policy, diversity, spiritual care, community health and social responsibility.

Castleman is currently the President and CEO of Syntiro Healthcare Services, Inc. He is also a director of FemPartners, Inc., a physician practice management company. He is chairman of Electro-Optical Sciences, Inc., a development stage diagnostic medical device company. Castleman brings extensive experience with private equity firms, securities analysts, investment banks and venture capital funds.

Lowenberg, with a distinguished career in the public and private sectors, currently consults with C-suite executives in healthcare and private equity firms and is a senior advisor to several healthcare companies. Lowenberg recently retired as president and CEO of Curascript, Inc., the specialty pharmacy business of Express Scripts, Inc.

"I could not be more pleased with the level of talent we have been fortunate to attract," said John Shufeldt, MD, CEO of NextCare, "I am confident that their experience, expertise and business acumen will steer us toward our vision of being the national leader in urgent care medicine."

Learn more about urgent care provider NextCare or find an immediate care clinic near you today.

About NextCare Urgent Care
Urgent care provider NextCare (www.nextcare.com) is the world's largest privately owned provider of urgent care and occupational medical services, known for bringing together service-driven healthcare and innovative medical technology to the delivery of medicine. NextCare operates 30 immediate care clinic facilities throughout Arizona, Colorado, Texas, Georgia, Virginia and North Carolina.

###


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Health IT Now! Coalition to Discuss the Urgent Need to Pass Health IT Legislation
2. Americans consider global warming an urgent threat, according to poll
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
5. Landmark WHO Report on Global Tobacco Epidemic Should Spur Urgent Action by Nations to Implement Proven Solutions
6. Studies on Urgent(R) PC to be Presented at the 2008 Society of Urologic Nurses and Associates Annual Symposium
7. Charlotte IVF Experts Issue Urgent Call for Egg Donors, Eye New Recruiting Tools
8. Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium
9. New MedPAC Report: Abbreviated Biogenerics Pathway Urgently Needed
10. Urgent Action Needed to Stem Rise in Health Care Costs
11. Aid Urgently Needed in Myanmar (Burma): Lutheran World Relief Responds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Urgent Care Provider NextCare Announces new Board of Directors
(Date:8/19/2017)... Texas (PRWEB) , ... August 19, 2017 , ... ... with contemporary illustrations of breastfeeding mothers. These illustrations show the diversity ... available in prints in a wide range of sizes. These illustrations are also ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions for ... agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation Systems, ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an industry leader, ... webinar, they will present the line of epMotion automated liquid handling system. This ... can automate everyday pipetting tasks. , Ideal for scientists and lab technicians with ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... assistance and financial planning services to communities in east Texas, is launching a ... Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 2017  Axium Pharmaceuticals Inc., the creator of the drug Truveta ... beginning stages of an IPO. The United States ... average cost of a prescription epilepsy drug being $450.00-$1200.00 for a one ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent $42 billion ...
(Date:8/14/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... second quarter ending June 30, 2017. ... of preparing for our pivotal Phase 3 trial to ... Lebovits , President and Chief Executive Officer of BrainStorm. ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: